AstraZeneca's Ruud Dobber Talks "America"
Ruud Dobber, answers the question, "What is the most surprising thing you've learned about America or Americans since you moved here and took over the US last year?"
Pharm Exec speaks with Ruud Dobber, who is president, AstraZeneca US and executive vice president, North America, to ask him the question "What is the most surprising thing you've learned about America or Americans since you moved here and took over the US last year?"
While Dobber has only been in this position for just over a year, he has provided the viewers with many insights within the healthcare system.
IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment
August 20th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.
AbbVie Presents New Data from Antibody-Drug Conjugates Across Multiple Indications at ASCO 2024
June 13th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Pedro Valencia, VP, Solid Tumor Pipeline Strategy & Execution, AbbVie, discusses data presented at ASCO from ABBV-400 and ABBV-706 in multiple studies.
Planning for Unique Challenges Faced by Cell & Gene Therapy Developers
May 8th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora, discusses the unique challenges that developers of cell and gene therapies need to plan for when building their channel strategy.
